πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,444 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6709858

Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Mar 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6699674

Expression and refolding of truncated recombinant major outer membrane protein antigen (R5

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6693130

Inhibitors of epoxide hydrolases for the treatment of hypertension

The Regents of the University of California Β· Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6692750

Alphavirus expression vector

Bioption AB Β· Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6689561

Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression

The Regents of the University of California Β· Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6685626

Compositions, devices, methods, and kits for induction of adhesions

Regeneration Technologies, Inc. Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6682741

&bgr;2 microglobulin fusion proteins and high affinity variants

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6673559

Met proto-oncogene and a method for predicting breast cancer progression

The United States of America as Represented by the Government of the Department of Health and Human Services Β· Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6670374

Swainsonine compounds as inhibitors of toxin receptor expression

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6642049

Human brain endothelial cells and growth medium and method for expansion of primitive CD34

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Nov 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6632628

Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

The Board of Regents of the University of Texas System Β· Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6630344

Diminishing viral gene expression by promoter replacement

Texas Systems, University of the Board of the Regents Β· Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6630167

Hyaluronic acid anti-adhesion barrier

United States Surgical Corporation Β· Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6613757

COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT

The Board of Regents of the University of Texas System Β· Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6607882

Regulation of endogenous gene expression in cells using zinc finger proteins

Sangamo Biosciences, Inc. Β· Granted Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6600030

Delayed progression to aids by a missense allele of the CCR2 gene

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6599744

Viral expression vectors comprising a ribosomal promoter sequence

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6592872

Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion prot

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6589507

Foaming antacid suspension tablets

DR. Regenold GmbH Β· Granted Tue Jul 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6566342

Gene therapy by secretory gland expression

The Regents of the University of California Β· Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6562347

Chemokine-tumor antigen fusion proteins as cancer vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6534310

Suppression of proteolytic activity by dysfunctional protease formation

The Regents of the University of California Β· Granted Tue Mar 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6534261

Regulation of endogenous gene expression in cells using zinc finger proteins

Sangamo Biosciences, Inc. Β· Granted Tue Mar 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6531506

Inhibitors of epoxide hydrolases for the treatment of hypertension

The Regents of the University of California Β· Granted Tue Mar 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired